Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 54273, 11 pages
http://dx.doi.org/10.1155/MI/2006/54273
Research Communication

Balance Between Pro- and Anti-Inflammatory Cytokines in Mice Treated With Centruroides noxius Scorpion Venom

Laboratorio de Toxicología, Facultad de Medicina de la Universidad Autónoma del Estado de Morelos, Cuernavaca 62210, Mexico

Received 21 June 2006; Revised 10 September 2006; Accepted 11 September 2006

Copyright © 2006 Vera L. Petricevich. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M Ismail, “The treatment of the scorpion envenoming syndrome: the Saudi experience with serotherapy,” Toxicon, vol. 32, no. 9, pp. 1019–1026, 1994. View at Publisher · View at Google Scholar
  2. M M Magalhães, M ES Pereira, C FS Amaral et al., “Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting,” Toxicon, vol. 37, no. 8, pp. 1155–1164, 1999. View at Publisher · View at Google Scholar
  3. V L Petricevich, “Cytokine and nitric oxide production following severe envenomation,” Current Drug Targets: Inflammation and Allergy, vol. 3, no. 3, pp. 325–332, 2004. View at Publisher · View at Google Scholar
  4. S Sofer, “Scorpion envenomation,” Intensive Care Medicine, vol. 21, no. 8, pp. 626–628, 1995. View at Publisher · View at Google Scholar
  5. A O'Garra, “Cytokines induce the development of functionally heterogeneous T helper cell subsets,” Immunity, vol. 8, no. 3, pp. 275–283, 1998. View at Publisher · View at Google Scholar
  6. S Romagnani, “Lymphokine production by human T cells in disease states,” Annual Review of Immunology, vol. 12, pp. 227–257, 1994. View at Publisher · View at Google Scholar
  7. J T van Dissel, P van Langevelde, R GJ Westendorp, K Kwappenberg, and M Frölich, “Anti-inflammatory cytokine profile and mortality in febrile patients,” Lancet, vol. 351, no. 9107, pp. 950–953, 1998. View at Publisher · View at Google Scholar
  8. T Jo, N Terada, Y Takauchi et al., “Cytotoxic actions of cytokines on cultured mouse luteal cells are independent of nitric oxide,” Journal of Steroid Biochemistry and Molecular Biology, vol. 55, no. 3-4, pp. 291–296, 1995. View at Publisher · View at Google Scholar
  9. P H van der Meide and H Schellekens, “Cytokines and the immune response,” Biotherapy, vol. 8, no. 3-4, pp. 243–249, 1996. View at Publisher · View at Google Scholar
  10. C Gerard, C Bruyns, A Marchant et al., “Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia,” Journal of Experimental Medicine, vol. 177, no. 2, pp. 547–550, 1993. View at Publisher · View at Google Scholar
  11. M Howard, T Muchamuel, S Andrade, and S Menon, “Interleukin 10 protects mice from lethal endotoxemia,” Journal of Experimental Medicine, vol. 177, no. 4, pp. 1205–1208, 1993. View at Publisher · View at Google Scholar
  12. M J Herbertson, H A Werner, C M Goddard et al., “Anti-tumor necrosis factor-a prevents decreased ventricular contractility in endotoxemic pigs,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 2, pp. 480–488, 1995. View at Google Scholar
  13. B E Barton, “IL-6: insights into novel biological activities,” Clinical Immunology and Immunopathology, vol. 85, no. 1, pp. 16–20, 1997. View at Publisher · View at Google Scholar
  14. M C Ruzek, A H Miller, S M Opal, B D Pearce, and C A Biron, “Characterization of early cytokine responses and an interleukin (IL)-6- dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection,” Journal of Experimental Medicine, vol. 185, no. 7, pp. 1185–1192, 1997. View at Publisher · View at Google Scholar
  15. Z Xing, J Gauldie, G Cox et al., “IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses,” Journal of Clinical Investigation, vol. 101, no. 2, pp. 311–320, 1998. View at Google Scholar
  16. F Ceciliani, A Giordano, and V Spagnolo, “The systemic reaction during inflammation: the acute-phase proteins,” Protein and Peptide Letters, vol. 9, no. 3, pp. 211–223, 2002. View at Publisher · View at Google Scholar
  17. Committe Members. International Society on Toxicology, Toxicon, vol. 30, pp. 1–12, 1992.
  18. V CBC Gebara, V L Petricevich, I Raw, and W Dias da Silva, “Effect of saponin from Quillaja saponaria (molina) on antibody, tumour necrosis factor and interferon-γ production,” Biotechnology and Applied Biochemistry, vol. 22, no. pt 1, pp. 31–37, 1995. View at Google Scholar
  19. J R Schumacher, A O'Garra, P Schrader et al., “Characterization of 4 monoclonal antibodies to mouse interleukin-5 and development of mouse and human IL-5 ELISA assays,” Journal of Immunology, vol. 141, no. 5, pp. 1575–1581, 1995. View at Google Scholar
  20. M R Ruff and G E Gifford, “Purification and physico-chemical characterization of rabbit tumor necrosis factor,” Journal of Immunology, vol. 125, no. 4, pp. 1671–1677, 1980. View at Google Scholar
  21. H HHW Schmidt, R Seifert, and E Bohme, “Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4,” FEBS Letters, vol. 244, no. 2, pp. 357–360, 1989. View at Publisher · View at Google Scholar
  22. M Ismail, “The scorpion envenoming syndrome,” Toxicon, vol. 33, no. 7, pp. 825–858, 1995. View at Publisher · View at Google Scholar
  23. E Kalapothakis and C Chávez-Olórtegui, “Venom variability among several Tityus serrulatus specimens,” Toxicon, vol. 35, no. 10, pp. 1523–1529, 1997. View at Publisher · View at Google Scholar
  24. D Hoffman, “Insect venom allergy, immunology, and immunotherapy,” in Handbook of Neural Toxins: Insect Poisons, Allergens, and Other Invertebrate Venoms, A T Tu, Ed., vol. 2, pp. 187–224, Marcel Dekker, New York, NY, 1984. View at Google Scholar
  25. V L Petricevich and C F Peña, “The dynamics of cytokine d nitric oxide secretion in mice injected with Tityus serrulatus scorpion venom,” Mediators of Inflammation, vol. 11, no. 3, pp. 173–180, 2002. View at Publisher · View at Google Scholar
  26. S F Barros, I Friedlanskaia, V L Petricevich, and T L Kipnis, “Local inflammation, lethality and cytokine release in mice injected with Bothrops atrox venom,” Mediators of Inflammation, vol. 7, no. 5, pp. 339–346, 1998. View at Publisher · View at Google Scholar
  27. V L Petricevich, C FP Teixeira, D V Tambourgi, and J M Gutiérrez, “Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms,” Toxicon, vol. 38, no. 9, pp. 1253–1266, 2000. View at Publisher · View at Google Scholar
  28. D V Tambourgi, V L Petricevich, F C Magnoli, S LMR Assaf, S Jancar, and W Dias da Silva, “Endotoxemic-like shock induced by Loxosceles spider venoms: pathological changes and putative cytokine mediators,” Toxicon, vol. 36, no. 2, pp. 391–403, 1998. View at Publisher · View at Google Scholar
  29. B Lomonte, A Tarkowski, and L A Hanson, “Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model,” Inflammation, vol. 17, no. 2, pp. 93–105, 1993. View at Publisher · View at Google Scholar
  30. N A De Rezende, M B Dias, D Campolina, C Chavez-Olortegui, C R Diniz, and C FS Amaral, “Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions,” American Journal of Tropical Medicine and Hygiene, vol. 52, no. 3, pp. 277–280, 1995. View at Google Scholar
  31. A Muraguchi, T Hirano, B Tang et al., “The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells,” Journal of Experimental Medicine, vol. 167, no. 2, pp. 332–344, 1988. View at Publisher · View at Google Scholar
  32. Y Takai, G G Wong, S C Clark, S J Burakoff, and S H Herrmann, “B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes,” Journal of Immunology, vol. 140, no. 2, pp. 508–512, 1988. View at Google Scholar
  33. J Gauldie, C Richards, D Harnish, P Lansdorp, and H Baumann, “Interferon β 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 20, pp. 7251–7255, 1987. View at Publisher · View at Google Scholar
  34. L Borish, R Rosenbaum, L Albury, and S Clark, “Activation of neutrophils by recombinant interleukin 6,” Cellular Immunology, vol. 121, no. 2, pp. 280–289, 1989. View at Publisher · View at Google Scholar
  35. Y Fong, K J Tracey, L L Moldawer et al., “Antibodies to cachectin/tumor necrosis factor reduce interleukin 1ß and interleukin 6 appearance during lethal bacteremia,” Journal of Experimental Medicine, vol. 170, no. 5, pp. 1627–1633, 1989. View at Publisher · View at Google Scholar
  36. C Haworth, F M Brennan, D Chantry, M Turner, R N Maini, and M Feldmann, “Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α,” European Journal of Immunology, vol. 21, no. 10, pp. 2575–2579, 1991. View at Google Scholar
  37. L Lepore, M Pennesi, S Saletta, S Perticarari, G Presani, and M Prodan, “Study of IL-2, IL-6, TNFα, IFNγ and β in the serum and synovial fluid of patients with juvenile chronic arthritis,” Clinical and Experimental Rheumatology, vol. 12, no. 5, pp. 561–565, 1994. View at Google Scholar
  38. K W Moore, A O'Garra, R W Malefyt, P Vieira, and T R Mosmann, “Interleukin-10,” Annual Review of Immunology, vol. 11, pp. 165–190, 1993. View at Publisher · View at Google Scholar
  39. A Marchant, J Devière, B Byl, D De Groote, J.-L Vincent, and M Goldman, “Interleukin-10 production during septicaemia,” Lancet, vol. 343, no. 8899, pp. 707–708, 1994. View at Publisher · View at Google Scholar
  40. H A Young and J R Ortaldo, “One-signal requirement for interferon-γ production by human large granular lymphocytes,” Journal of Immunology, vol. 139, no. 3, pp. 724–727, 1987. View at Google Scholar
  41. C A Dinarello, J G Cannon, and S M Wolff, “New concepts on the pathogenesis of fever,” Reviews of Infectious Diseases, vol. 10, no. 1, pp. 168–189, 1988. View at Google Scholar
  42. S Okusawa, J A Gelfand, T Ikejima, R J Connolly, and C A Dinarello, “Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition,” Journal of Clinical Investigation, vol. 81, no. 4, pp. 1162–1172, 1988. View at Google Scholar
  43. D G Remick, R M Strieter, M K Eskandari et al., “Role of tumor necrosis factor-a in lipopolysaccharide-induced pathologic alterations,” American Journal of Pathology, vol. 136, no. 1, pp. 49–60, 1990. View at Google Scholar
  44. T van der Poll, J Jansen, M Levi, H ten Cate, J W ten Cate, and S JH van Deventer, “Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees,” Journal of Experimental Medicine, vol. 180, no. 5, pp. 1985–1988, 1994. View at Publisher · View at Google Scholar